1st Quarter - Report

FORBES-TATE for NOVARTIS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to the implementation of H.R.2471 - Consolidated Appropriations Act, 2022; Issues related to COVID 19 funding for BARDA; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). S.4348. - FDASLA Act of 2022 (117th Congress), S.4535 - FDASRA Act of 2022 (117th Congress), H.R.7658 - To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships, provisions regarding reauthorization of FDA User Fee Programs (117th Congress).

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7658 (118th), H.R. 5376 (118th), S.Con.Res. 14 (118th), S. 4535 (118th), S. 4348 (118th), H.R. 2471 (118th)

Medicare/Medicaid MMM

Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (118th), H.R. 5376 (118th)

Trade (domestic/foreign) TRD

Issues related to prescription drug pricing; issues related to World Trade Organization IP waiver; issues related to pharmaceutical intellectual property; issues related to international trade.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (118th), H.R. 5376 (118th)

Copyright/Patent/Trademark CPT

Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (118th)

Taxation/Internal Revenue Code TAX

Issues related to implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.